Most Recent
Generic drug maker Sun Pharma has succeeded in invalidating Otsuka Pharmaceutical’s patent for an injectable, controlled release form of the Japanese drug maker's top-selling antipsychotic Abilify.
Ahead of an eight-week trial in an investor class action in July, ratings agency S&P has lost its bid to throw out the entirety of the expert evidence in the case.
Construction PRO
The developer of a suite of Holiday Inn Express hotels has succeeded in its appeal of a ruling that laid bare privileged material connected to its lawyers' bills.
The High Court has overturned a controversial decision that put a judge on the hook for a man’s false imprisonment, finding that all judges are immune from civil suits for acts done in the performance of their judicial duties.
A class action against BHP can include in the group member definition investors who bought shares on secondary platforms, but the change can't apply retroactively.
A trans woman who won her discrimination case against the Giggle for Girls app and its CEO Sal Grover has launched a cross-appeal against the landmark decision.
Construction PRO
BESIX Watpac and Frasers Property are fighting claims they are liable for defects in two residential complexes in the Sydney suburb of Chippendale, including the $2 billion One Central Park towers.
Construction PRO
Lendlease has abandoned its bid to purchase a parcel of land owned by one of Australia’s oldest families for well below market value as part of its project to develop 6,700 homes in Campbelltown, Sydney.
A class action against Exactech over allegedly faulty joint implants has been stayed pending its US-based parent company’s bankruptcy proceedings.
A judge has rejected HSU secretary Diana Asmar's argument that a case against her over an alleged $2.7 million false invoicing scheme should be stayed because criminal charges were “on the cards”.